| Disease | Target Count | Z-score | Confidence |
|---|---|---|---|
| Prostatic Neoplasms | 495 | 0.0 | 0.0 |
| Disease | Target Count | P-value |
|---|---|---|
| malignant mesothelioma | 3232 | 6.1e-08 |
| osteosarcoma | 7950 | 1.5e-06 |
| ovarian cancer | 8520 | 4.0e-06 |
| medulloblastoma, large-cell | 6241 | 4.2e-05 |
| adult high grade glioma | 3801 | 6.7e-05 |
| glioblastoma | 5792 | 1.6e-04 |
| primitive neuroectodermal tumor | 3035 | 1.9e-04 |
| psoriasis | 6694 | 3.0e-04 |
| intraductal papillary-mucinous adenoma (IPMA) | 2955 | 6.2e-04 |
| tuberculosis and treatment for 6 months | 409 | 1.8e-03 |
| atypical teratoid / rhabdoid tumor | 5112 | 2.2e-03 |
| subependymal giant cell astrocytoma | 2287 | 6.2e-03 |
| oligodendroglioma | 2850 | 2.0e-02 |
| astrocytic glioma | 2597 | 2.2e-02 |
| group 3 medulloblastoma | 4104 | 2.3e-02 |
| spina bifida | 1074 | 3.7e-02 |
| ependymoma | 4679 | 4.1e-02 |
| Disease | Target Count | Z-score | Confidence |
|---|---|---|---|
| Angelman syndrome | 34 | 3.62 | 1.8 |
| Prader-Willi syndrome | 48 | 3.337 | 1.7 |
| Disease | log2 FC | p |
|---|---|---|
| adult high grade glioma | -2.100 | 6.7e-05 |
| astrocytic glioma | -1.100 | 2.2e-02 |
| atypical teratoid / rhabdoid tumor | -1.600 | 2.2e-03 |
| ependymoma | -1.100 | 4.1e-02 |
| glioblastoma | -1.300 | 1.6e-04 |
| group 3 medulloblastoma | -1.200 | 2.3e-02 |
| intraductal papillary-mucinous adenoma (... | 1.200 | 6.2e-04 |
| malignant mesothelioma | -3.700 | 6.1e-08 |
| medulloblastoma, large-cell | -2.000 | 4.2e-05 |
| oligodendroglioma | -1.400 | 2.0e-02 |
| osteosarcoma | -1.919 | 1.5e-06 |
| ovarian cancer | -1.100 | 4.0e-06 |
| primitive neuroectodermal tumor | -1.800 | 1.9e-04 |
| psoriasis | -2.400 | 3.0e-04 |
| spina bifida | -1.216 | 3.7e-02 |
| subependymal giant cell astrocytoma | -2.204 | 6.2e-03 |
| tuberculosis and treatment for 6 months | -1.100 | 1.8e-03 |
MDGSHSAALKLQQLPPTSSSSAVSEASFSYKENLIGALLAIFGHLVVSIALNLQKYCHIRLAGSKDPRAY 1 - 70 FKTKTWWLGLFLMLLGELGVFASYAFAPLSLIVPLSAVSVIASAIIGIIFIKEKWKPKDFLRRYVLSFVG 71 - 140 CGLAVVGTYLLVTFAPNSHEKMTGENVTRHLVSWPFLLYMLVEIILFCLLLYFYKEKNANNIVVILLLVA 141 - 210 LLGSMTVVTVKAVAGMLVLSIQGNLQLDYPIFYVMFVCMVATAVYQAAFLSQASQMYDSSLIASVGYILS 211 - 280 TTIAITAGAIFYLDFIGEDVLHICMFALGCLIAFLGVFLITRNRKKPIPFEPYISMDAMPGMQNMHDKGM 281 - 350 TVQPELKASFSYGALENNDNISEIYAPATLPVMQEEHGSRSASGVPYRVLEHTKKE 351 - 406 //
